Vaccine Research Center is a clinical research unit operating within the Faculty of Medicine and Life Sciences at the University of Tampere. It carries out clinical trials of vaccines in co-operation with the pharmaceutical industry.
Vaccine Research Center was formally established in 2004. However, vaccine trials have been carried out in Tampere since 1979, and in accordance with Good Clinical Practice (GCP) since 1991.
Vaccine Research Center employs approximately 100 full-time or part-time professionals. All staff are employed by the University of Tampere. The Center currently operates a network of 10 regional vaccine research clinics, which staff includes professional study nurses, medical laboratory technologists and investigators. Vaccine Research Center is conducted by professor Timo Vesikari.
The network of clinics enables the Center to carry out extensive national trials and contribute strongly to large multinational studies. Leading international vaccine manufacturers have a high opinion of the Center as a partner.
Vaccine Research Center has specialized in viral vaccines in children, and is well known for its studies of varicella, influenza and rotavirus. Recent studies in Finland have had a pivotal role in registration of two new rotavirus vaccines in the EU and licensure of one rotavirus vaccine in the US in 2006. The studies done by the Center have also been important for the US registration of live attenuated intranasal influenza vaccine. In the past, studies in Tampere were in a key position for registration of varicella vaccine in Europe and, more recently, in the registration of MMR+varicella vaccine.
Studies since 2007 focus on meningococcal and pneumococcal conjugate vaccines, new hepatitis B vaccines, new epidemic and pandemic influenza vaccines, various combination vaccines and coadministration schedules in children. In addition to childhood vaccinations, the Center also conducts studies in adults and in the elderly. These studies evaluate vaccines against herpes zoster and seasonal and pandemic influenza.
All research projects are carried out in accordance with GCP and the laws, regulations and EU directives concerning clinical trials of pharmaceuticals. All personnel have been trained to GCP and electronic data transfer. Competent and experienced personnel guarantee that the research data are of the highest quality. The trials in Finland are approved by the Finnish Medicines Agency (Fimea) and the National Committee on Medical Research Ethics (TUKIJA) or the Ethics Committee of the Pirkanmaa Hospital District.
Co-operation / Sponsors
* Berna Biotech Ltd
* FIT Biotech
* GlaxoSmithKline Biologicals
* MedImmune Vaccines
* Merck & Co., Inc.
* Novartis Vaccines
* Sanofi Pasteur
* Sanofi Pasteur MSD
* Solvay Pharmaceuticals
* Wyeth Vaccines
Co-operation / CRO:s
* Smerud Medical Research
* Trial Form Support (TFS)
You may upload our brochure from here: